Copeptin During a Standardized Psychological Stress Test (PsyCo)

September 8, 2014 updated by: University Hospital, Basel, Switzerland
The aim of the PsyCo Study is to determine whether psychological Stress has an influence on copeptin levels.

Study Overview

Status

Completed

Conditions

Detailed Description

healthy volunteers undergo the TSST and stress hormones as cortisol and copeptin are measured

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Basel-Stadt
      • Basel, Basel-Stadt, Switzerland, 4031
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

healthy adults

Description

Inclusion Criteria:

•Aged over 18 years

Exclusion Criteria:

  • Intake of any kind of medication (except birth control pill)
  • BMI >30 kg/m2
  • Evidence of any acute illness
  • History of chronic illness
  • Baseline glucose level >7 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
no treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in copeptin levels after a psychological stress test in healthy volunteers
Time Frame: 30min before, at time point 0, +10, +20, +40, +60 after the psychological stress test
30min before, at time point 0, +10, +20, +40, +60 after the psychological stress test

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes in copeptin levels after a psychological stress test in patients with central diabetes insipidus
Time Frame: Timpepoint 0, +10, +20, +40, +60 after the psychological stress test
Timpepoint 0, +10, +20, +40, +60 after the psychological stress test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mirjam Christ-Crain, Prof.Dr.med.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

February 1, 2014

Study Registration Dates

First Submitted

May 13, 2013

First Submitted That Met QC Criteria

May 27, 2013

First Posted (Estimate)

May 31, 2013

Study Record Updates

Last Update Posted (Estimate)

September 9, 2014

Last Update Submitted That Met QC Criteria

September 8, 2014

Last Verified

September 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

3
Subscribe